JNJ up +0.42% percent Today $JNJ High is at 108.69 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 1:33 PM

JNJ up +0.42% percent Today $JNJ High is at 108.69 and the Low 107.61 with current volume of 894,784.

Recent News posted below.

Johnson & Johnson JNJ other info.
http://investorshangout.com/Johnson--Johnson-JNJ-51518/

JNJ Johnson & Johnson Recent Headline News

DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - 2 hrs 17 mins ago
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 108.30 (+0.14), ABT: 43.90 (+0.09), DXCM: 52.34 (-0.39), MDT: 69.54 (+0.59)

Early Glance: Medical Devices companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.54 (+0.59), BAX: 71.99 (+0.24)

Early Glance: Pharmaceuticals companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)

5 Rocket Stocks to Buy as Earnings Season Ends: Southwest Airlines and More
at The Street - Mon Nov 17, 9:17AM CST
From a momentum standpoint, stocks are well-positioned to keep up their upside action as we head into the final stretch of 2014.
JNJ: 108.30 (+0.14), ORLY: 177.64 (-2.24), ED: 62.52 (+0.49), LUV: 39.45 (+0.50), CRM: 62.82 (-1.09)

Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.30 (+0.14), GILD: 100.44 (-1.62), ABBV: 65.14 (+1.14), CELG: 104.66 (+0.61)

Forget Marijuana! This Is a Much Smarter Investment
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 16, 11:11AM CST
Source: Flickr user Oswaldo. Although marijuana initiatives didn't log a perfect sweep in this year's midterm elections, the momentum behind the legalization movement remains intact. Two states (Oregon and Alaska), as well as Washington, D.C.,...
JNJ: 108.30 (+0.14), INSY: 38.50 (-0.07), GWPH: 75.31 (-0.32), GSK: 45.93 (+0.19), NVS: 94.54 (+0.59)

Value Investors' Most Loved Stocks In Q3 2014
Trading Mates Stock Advisor - at Seeking Alpha - Sun Nov 16, 8:09AM CST

NOV: 71.80 (+0.46), JNJ: 108.30 (+0.14), IBM: 164.48 (+0.32), WMT: 83.51 (+0.55), BAC: 17.07 (-0.07), BEN: 56.30 (-0.08), ACN: 84.69 (+0.05), SLB: 95.98 (+0.66), ORCL: 41.18 (+0.34)

3 Ways High-Yield Dividend Stocks Can Help You Recreate Warren Buffett's Investing Success
Adam Galas, The Motley Fool - Motley Fool - Sat Nov 15, 6:05PM CST
Many people consider Warren Buffett the greatest investor in history and it's not hard to understand why. According to a 2012 Yale study, Buffett's company, Berkshire Hathaway , had the best risk-adjusted return of any company or mutual fund that...
KMI: 39.99 (+0.62), MMM: 159.04 (+0.19), JNJ: 108.30 (+0.14), LNCO: 20.39 (-0.54), IBM: 164.48 (+0.32), WFC: 53.39 (+0.04), SDRL: 20.86 (+0.08), PG: 87.78 (-0.33), LINE: 22.37 (-0.28), VNR: 23.93 (-0.55), CL: 67.81 (+0.25)

Johnson & Johnson Part VI: 'Magic Pants' And 'Doubling Pennies'
Robert Honeywill - Seeking Alpha - Sat Nov 15, 6:00AM CST
In Part V of this series, I provided 4 scenarios (8 Cases) illustrating the potential financial outcomes for investors in Johnson & Johnson (NYSE: JNJ ) under changing PE ratios, which are a reflection of changing share prices and changing...
JNJ: 108.30 (+0.14)

Retirement Strategy: Annuities Vs. Dividend Growth Investing For A Lifetime Income
Regarded Solutions - at Seeking Alpha - Fri Nov 14, 11:01PM CST

KO: 42.94 (+0.21), T: 35.90 (unch), JNJ: 108.30 (+0.14), GE: 26.65 (+0.19), XOM: 95.04 (-0.05), MCD: 95.84 (-0.37), PG: 87.77 (-0.34), CVX: 115.98 (-0.34), AAPL: 114.00 (-0.18), WAG: 66.24 (-0.69)

Final Glance: Pharmaceuticals companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)

Final Glance: Medical Devices companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.53 (+0.58), BAX: 71.99 (+0.24)

Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 304.67 (-0.76), JNJ: 108.30 (+0.14), GERN: 3.02 (+0.26), AFFX: 9.39 (-0.32)

Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 39.30 (-0.50), AMZN: 321.03 (-6.79), JNJ: 108.30 (+0.14), HTZ: 22.17 (+0.48), GERN: 3.02 (+0.26), HAL: 49.82 (-5.26), JWN: 73.33 (-0.84), NOK: 7.66 (-0.20), BHI: 66.27 (+6.38)

Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.30 (+0.14), GERN: 3.02 (+0.26)

Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:39PM CST
Mallinckrodt (MNK) received a setback when the FDA informed the company that its methylphenidate hydrochloride extended-release tablets, USP (CII) might not be therapeutically equivalent to Johnson & Johnson's (JNJ) Concerta.
MNK: 88.39 (+0.28), BIIB: 304.67 (-0.76), JNJ: 108.30 (+0.14), ACT: 247.01 (+3.24)

Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 39.30 (-0.50), JNJ: 108.30 (+0.14), HTZ: 22.17 (+0.48), VA: 30.98 (+0.98), GERN: 3.02 (+0.26), JWN: 73.33 (-0.84)

Midday Glance: Pharmaceuticals companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)

Midday Glance: Medical Devices companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.53 (+0.58), BAX: 71.99 (+0.24)

Johnson & Johnson (JNJ) Stock Research Links

JNJ Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Admetec Shines Bright with New High-Magnification Headlights

Admetec's Leap into Advanced Optical Solutions In the world of optical magnification, getting the right balance of visibility and comfort hasn't always been a straightforward journey. Now, Admetec, coming out of Haifa, Israel, is throwing a game-changer into the mix with their announcement of the Butterfly EVO+ and Orchid+ series. These ain't just any old headlights;...

Duke Energy's $500K Push Against South Carolina Hunger

A Battle Cry Against Hunger Look, there’s no shortage of firms tossing around cash as PR stunts. But Duke Energy’s latest campaign to tackle hunger in South Carolina right at the root is one effort that seems to echo with a real bang. Coming at us with more than $500,000 in support for nearly 70 organizations across the state, they’re not just talking the talk. This...

Jungbunzlauer Introduces Johan Westman to Its Board

A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...

Sempra Shines with Robust Q3 2026 Financials

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Chris Auffenberg Delivers Ford Blue Advantage Gains

Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...

Wheels Up Expands Fleet with New Phenom 300E Jets

Wheels Up's New Horizons with Phenom 300E Jets Wheels Up Experience Inc. (NYSE: UP) just dropped a bombshell with their plan to purchase six spanking new Phenom 300E jets from Embraer (NYSE: EMBJ). This ain't just another lease agreement; this is their first-ever direct buy from Embraer, and it's set to add some serious flair to their fleet. Setting the Stage for Growth...

Strategies for Maintaining Water Quality in NH Homes

Protect Your Water: Steps to Safe Drinking Imagine turning on your kitchen tap, and instead of refreshing, clean water, you get a murky mystery. Not exactly anyone's dream scenario, right? Enter Sean McGorry and his down-to-earth guide to water quality for New Hampshire homesteaders. It's not rocket science, but the whispers of neglected water systems tell tales of...

Borussia Dortmund's Q1 2026/2027 Earnings Slip Amid Challenges

An Uneven Start to Borussia Dortmund's Financial Year Every finance year kickoff has its tales, and Borussia Dortmund's start for 2026/2027 is no different. The embattled team has been juggling a mixed bag of financial outcomes, darting through initial challenges with a revenue that hovers slightly above the previous year's mark. Revenue crept up to EUR 107.4 million,...

Drone Composites Market Set for Major Growth by 2031

Drone Composites: A Market Poised for Surge Strap in, folks! The drone composites market is gearing up for a wild ride, projected to nearly double from $7.06 billion in 2026 to a whopping $13.59 billion by 2031. That's a solid 14% compound annual growth rate (CAGR) for those keeping score at home. With those numbers, it's no wonder market players are strategizing hard to...

NIH Seeks AI Solutions for Kidney Disease Breakthroughs

A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...